RODEO THERAPEUTICS
Rodeo Therapeutics is a drug development company focused on novel enzyme target and biological pathway that play a critical role in tissue repair and regeneration. Rodeo’s initial goal is to develop novel small molecules therapies for the treatment of inflammatory bowel disease and the promotion of blood cell reconstitution following bone marrow transplant.
RODEO THERAPEUTICS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2017-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.rodeotherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(206)957-7300
Email Addresses:
[email protected]
Total Funding:
14.85 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail GoDaddy Network Solutions DNS
Similar Organizations
Anexigen
Anexigen is a developer of novel methods and compositions designed to combat existing and burgeoning antimicrobial threats.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Johnson & Johnson Innovation
Johnson & Johnson Innovation investment in Series A - Rodeo Therapeutics
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series A - Rodeo Therapeutics
Accelerator Corp.
Accelerator Corp. investment in Series A - Rodeo Therapeutics
Washington Research Foundation
Washington Research Foundation investment in Series A - Rodeo Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series A - Rodeo Therapeutics
Watson Fund
Watson Fund investment in Series A - Rodeo Therapeutics
Eli Lilly
Eli Lilly investment in Series A - Rodeo Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Rodeo Therapeutics
WuXi AppTec
WuXi AppTec investment in Series A - Rodeo Therapeutics
Official Site Inspections
http://www.rodeotherapeutics.com
- Host name: 199.59.243.227
- IP address: 199.59.243.227
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Rodeo Therapeutics"
Amgen to Acquire Rodeo Therapeutics Corporation
Rodeo's 15-PGDH program is a strong strategic fit with Amgen 's inflammation portfolio and efforts to develop first-in-class therapeutics for patients.See details»
Rodeo Therapeutics - Crunchbase Company Profile & Funding
Rodeo Therapeutics is a developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types.See details»
Rodeo Therapeutics - Craft
Rodeo Therapeutics is a preclinical-stage biopharmaceutical company. It is focused on novel enzyme targets and biological pathways that play a critical role in tissue repair and regeneration.See details»
Rodeo Therapeutics - VentureRadar
We are a clinically focused biotechnology company developing innovative therapeutics that address global unmet needs in the primary areas of stem cell technologies, regenerative …See details»
Rodeo Therapeutics Company Profile 2024: Valuation, …
Developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types.See details»
Amgen buys inflammatory diseases drug firm Rodeo for up to …
Mar 31, 2021 · Rodeo is a privately held biopharmaceutical company based in Seattle that develops small-molecule therapies designed to promote regeneration and repair of several …See details»
Amgen (AMGN) to Boost Inflammation Pipeline With Rodeo Buyout
Amgen Inc. AMGN announced an agreement to acquire Seattle, WA-based privately held biopharmaceutical company, Rodeo Therapeutics Corporation, which is engaged in …See details»
Amgen Snaps Up Rodeo Therapeutics For $721M
Mar 31, 2021 · Amgen Inc. has agreed to acquire private biopharmaceutical company Rodeo Therapeutics Corporation for a total consideration of $721 million. This includes a $55 million upfront payment and...See details»
Amgen plans acquisition of Rodeo Therapeutics - PMLiVE
Mar 31, 2021 · Amgen has agreed to acquire US-based biopharma company Rodeo Therapeutics to strengthen its anti-inflammatory portfolio. Amgen will pay $55m upfront, as well as potential …See details»
Amgen signs agreement to acquire Rodeo …
Mar 31, 2021 · Amgen has entered an agreement to acquire US-based biopharmaceutical company Rodeo Therapeutics for up to $721m. According to the deal, Amgen will acquire all outstanding shares of Rodeo for an upfront …See details»
Amgen agrees to acquire biopharmaceutical company Rodeo …
Biotechnology company Amgen has agreed to acquire privately held biopharmaceutical company Rodeo Therapeutics. Under the deal, the company will acquire all Rodeo Therapeutics’ …See details»
Amgen to Acquire Rodeo Therapeutics for up to $721 Million
Mar 31, 2021 · Amgen announced on March 30, 2021 that it has acquired Rodeo Therapeutics, a US-based biopharmaceutical company focused on small-molecule therapy development, for …See details»
Amgen Bets On Regenerative Immunology With Rodeo …
Mar 31, 2021 · With blockbuster immunology treatments Enbrel (via $16 billion acquisition of Immunex in 2009) and Otezla (added in 2013 via $13 billion deal) already in its bag, Amgen …See details»
Rodeo Therapeutics | VentureRadar
Website: http://rodeotherapeutics.com. Rodeo Therapeutics is focused on developing small-molecule therapies that increase tissue levels of prostaglandin PGE2.See details»
Rodeo Therapeutics Company Information - Funding, Investors, …
Http://rodeotherapeutics.com/ Rodeo Therapeutics is a preclinical-stage biotech company focused on first in class small molecule modulators of prostaglandin biology for enhancing tissue repair …See details»
Amgen to Acquire Rodeo Therapeutics Corporation - PR Newswire
Mar 30, 2021 · Rodeo's 15-PGDH program is a strong strategic fit with Amgen's inflammation portfolio and efforts to develop first-in-class therapeutics for patients.See details»
Rodeo Therapeutics Corp. | Insights
Jul 28, 2021 · Who: Amgen/Rodeo Therapeutics What: Amgen agreed to buy privately held Rodeo for $55m and potential earnouts. Why: In its second M&A deal of the year, Amgen …See details»
Rodeo Therapeutics Nominates First-in-Class Oral Development …
Aug 31, 2020 · SEATTLE-- ( BUSINESS WIRE )--Rodeo Therapeutics Corporation, a company developing small-molecule therapies designed to promote regeneration and repair of multiple …See details»
Rodeo Therapeutics - Overview, News & Competitors - ZoomInfo
View Rodeo Therapeutics (www.rodeotherapeutics.com) location in Washington, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
SEATTLE, WA August 31, 2020 - acceleratorlsp.com
Rodeo Therapeutics Nominates First-in-Class Oral Development Candidate for Inflammatory Bowel Disease Rodeo Therapeutics nominates Candidate RTX-1688, a first-in-class oral small …See details»